HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomomasa Takamiya Selected Research

Brain Natriuretic Peptide (Natrecor)

12/2016The impact of B-type natriuretic peptide levels on the suppression of accompanying atrial fibrillation in Wolff-Parkinson-White syndrome patients after accessory pathway ablation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomomasa Takamiya Research Topics

Disease

7Atrial Fibrillation
01/2021 - 12/2016
4Tachycardia (Tachyarrhythmias)
01/2021 - 04/2019
3Ventricular Tachycardia
03/2024 - 07/2019
1Cicatrix (Scar)
12/2023
1Pericardial Effusion
12/2023
1Heart Failure
01/2021
1Infarction (Infarctions)
07/2019
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
12/2016
1Hypertension (High Blood Pressure)
12/2016

Drug/Important Bio-Agent (IBA)

3Anti-Arrhythmia AgentsIBA
12/2020 - 04/2019
1SteamIBA
12/2023
1Isoproterenol (Isoprenaline)FDA LinkGeneric
04/2019
1Brain Natriuretic Peptide (Natrecor)FDA Link
12/2016

Therapy/Procedure

7Catheter Ablation
03/2024 - 04/2019
2Catheters
12/2023 - 12/2020
2Radiofrequency Ablation
12/2020 - 01/2019
1Renal Dialysis (Hemodialysis)
12/2020